← Back to Research← 返回研究
GILDEarnings ReleaseSource checkedAugust 5, 2026by InvestLog AI

GILD earnings release — EPS beat +7.0% · revenue beat +5.5%吉利德 (GILD) 财报发布 — EPS 高于预期+7.0% · 营收 高于预期+5.5%

Key Results

Gilead Sciences, Inc. (GILD) published results at 2026-08-04 21:41:00.

Actual vs Consensus

  • EPS: $-6.75 vs $-7.26 estimate, beat+7.0%.
  • Revenue: $7.8B vs $7.4B estimate, beat+5.5%.
  • Profitability and Cash Flow

  • Period: 2026 Q2 period ended 2026-06-30
  • Revenue: $7.8B; YoY: +10.2%; QoQ: +12.1%
  • Gross profit: $6.2B; Gross margin: 79.8%
  • Operating income: -$10.4B; YoY: -520.1%; QoQ: -501.9%
  • Net income: -$10.5B; GAAP diluted EPS: $-8.45; YoY: -635.5%; QoQ: -619.3%
  • Operating cash flow: $3.6B; Capex: $117M; Free cash flow: $3.5B
  • Cash: $3.2B; Total debt: $0; Net cash: $3.2B
  • Official release: CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results

    核心结果

    吉利德 (GILD) 已发布财报,发布时间:2026-08-04 21:41:00。

    实际值与市场预期

  • EPS:$-6.75 vs $-7.26 预期,高于预期+7.0%。
  • 营收:$7.8B vs $7.4B 预期,高于预期+5.5%。
  • 财务指标

  • 期间:2026 Q2 period ended 2026-06-30
  • 营收:$7.8B;同比:+10.2%;环比:+12.1%
  • 毛利润:$6.2B;毛利率:79.8%
  • 经营利润:-$10.4B;同比:-520.1%;环比:-501.9%
  • 净利润:-$10.5B;GAAP 稀释 EPS:$-8.45;同比:-635.5%;环比:-619.3%
  • 经营现金流:$3.6B;资本开支:$117M;自由现金流:$3.5B
  • 现金:$3.2B;总债务:$0;净现金:$3.2B
  • 官方公告:CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results

    This earnings research was prepared from company results, regulatory filings, financial statements, and earnings-call transcripts or official replays. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件、财务报表,以及财报电话会议记录或官方回放整理。内容仅供参考,不构成投资建议。